Dual Receptor-Targeted and Redox-Sensitive Polymeric Micelles Self-Assembled from a Folic Acid-Hyaluronic Acid-SS-Vitamin E Succinate Polymer for Precise Cancer Therapy
Open Access
- 1 April 2020
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 15, 2885-2902
Abstract
Purpose: Poor site-specific delivery and insufficient intracellular drug release in tumors are inherent disadvantages to successful chemotherapy. In this study, an extraordinary polymeric micelle nanoplatform was designed for the efficient delivery of paclitaxel (PTX) by combining dual receptor-mediated active targeting and stimuli response to intracellular reduction potential. Methods: The dual-targeted redox-sensitive polymer, folic acid-hyaluronic acid-SS-vitamin E succinate (FHSV), was synthesized via an amidation reaction and characterized by 1H-NMR. Then, PTX-loaded FHSV micelles (PTX/FHSV) were prepared by a dialysis method. The physiochemical properties of the micelles were explored. Moreover, in vitro cytological experiments and in vivo animal studies were carried out to evaluate the antitumor efficacy of polymeric micelles. Results: The PTX/FHSV micelles exhibited a uniform, near-spherical morphology (148.8 ± 1.4 nm) and a high drug loading capacity (11.28% ± 0.25). Triggered by the high concentration of glutathione, PTX/FHSV micelles could quickly release their loaded drug into the release medium. The in vitro cytological evaluations showed that, compared with Taxol or single receptor-targeted micelles, FHSV micelles yielded higher cellular uptake by the dual receptor-mediated endocytosis pathway, thus leading to significantly superior cytotoxicity and apoptosis in tumor cells but less cytotoxicity in normal cells. More importantly, in the in vivo antitumor experiments, PTX/FHSV micelles exhibited enhanced tumor accumulation and produced remarkable tumor growth inhibition with minimal systemic toxicity. Conclusion: Our results suggest that this well-designed FHSV polymer has promising potential for use as a vehicle of chemotherapeutic drugs for precise cancer therapy.Keywords
This publication has 57 references indexed in Scilit:
- The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapyJournal of Drug Targeting, 2013
- Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumorsBiomaterials, 2013
- Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancerBiomaterials, 2012
- Transferrin-Conjugated Micelles: Enhanced Accumulation and Antitumor Effect for Transferrin-Receptor-Overexpressing Cancer ModelsMolecular Pharmaceutics, 2012
- Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxelBiomaterials, 2012
- Targeting Tumor Cells through Chitosan-Folate Modified Microcapsules Loaded with CamptothecinBioconjugate Chemistry, 2011
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdvanced Drug Delivery Reviews, 2011
- Comparison of anti-tumor efficacy of paclitaxel delivered in nano- and microparticlesInternational Journal of Pharmaceutics, 2010
- Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assayAnalytical Biochemistry, 2005
- Paclitaxel in cancer therapyExpert Opinion on Pharmacotherapy, 2002